1. Home
  2. JG vs LITS Comparison

JG vs LITS Comparison

Compare JG & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Mobile Limited

JG

Aurora Mobile Limited

N/A

Current Price

$6.35

Market Cap

29.3M

Sector

Technology

ML Signal

N/A

LITS

Lite Strategy Inc.

N/A

Current Price

$1.00

Market Cap

25.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JG
LITS
Founded
2012
2000
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.3M
25.7M
IPO Year
2018
2003

Fundamental Metrics

Financial Performance
Metric
JG
LITS
Price
$6.35
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.6K
142.8K
Earning Date
05-28-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.20
$0.69
52 Week High
$10.04
$3.03

Technical Indicators

Market Signals
Indicator
JG
LITS
Relative Strength Index (RSI) 54.34 54.23
Support Level $5.25 $0.88
Resistance Level $6.83 $0.99
Average True Range (ATR) 0.52 0.06
MACD 0.01 0.01
Stochastic Oscillator 52.38 58.19

Price Performance

Historical Comparison
JG
LITS

About JG Aurora Mobile Limited

Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates in one segment and generates revenues from SAAS Businesses.

About LITS Lite Strategy Inc.

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Share on Social Networks: